All In Biotech

Investigational drug · Phase 3

TLL-018

Not approved by FDA. In 8 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria.

Phase 3

Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

8

6 still active

All registered trials

14

Any phase or sponsor naming "TLL-018"

First trial start

2023

Jan 19, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "TLL-018", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Chronic Spontaneous Urticaria (CSU)
  • Rheumatoid Arthritis
  • Chronic Spontaneous Urticaria
  • Rheumatoid Arthritis (RA)
  • Atopic Dermatitis (AD)
  • Plaque Psoriasis

Approved drugs for the same conditions: Rheumatoid arthritis · Plaque psoriasis · Atopic dermatitis (eczema) · Chronic hives (urticaria) · Immunology and inflammation · Dermatology

Largest trials

Live from ClinicalTrials.gov: studies naming "TLL-018" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 6 on PubMed

Also in development for Chronic Spontaneous Urticaria (CSU)

  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • LP-003SinglePhase 39 trials

    Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies

  • ICP-332Phase 34 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Non Segmental Vitiligo, Chronic Spontaneous Urticaria (CSU), Atopic Dermatitis

  • Shanghai Mabgeek Biotech.Co.Ltd · Atopic Dermatitis, Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU)

  • LesigerceptPhase 21 trial

    Yuhan Corporation · Allergic Diseases, Chronic Spontaneous Urticaria (CSU)

  • NN2802Phase 21 trial

    Novelty Nobility, Inc. · Healhty, Chronic Spontaneous Urticaria (CSU)

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.